Bajaj Healthcare Share Price

Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. It operates through three segments: APIs, Finished Dosage Formulations (FDFs), and Intermediates. Its APIs include Ascorbic Acid IP, Sodium Ascorbate, Ferrous Ascorbate, and others. Its Intermediary products include Calcium Phosphoryl Choline Chloride (CPCC) and Chlorhexidine (CH Base). It offers a range of FDFs forms, including tablets, caplets, capsules, and oral powders, all available in bulk quantities. The FDFs products include Cholecalciferol Sachet, Ticagrelor Tablet, Pancreatin Capsules, levofloxacin Tablets IP, Bisacodyl Tablet IP, and others. As of 16 Jun 2026, Bajaj Healthcare share price is ₹302.30. The stock opened at ₹303.00, compared to its previous close of ₹299.20. During today's trading session, Bajaj Healthcare share price moved in the range of ₹296.85 to ₹304.20, with an average price of ₹300.52 for the day. Looking at its last 52-week, the stock has touched a low of ₹296.85 and a high of ₹304.20. On the performance front, Bajaj Healthcare share price has declined by 27.05% over the last six months and is down 42.05% on a year-on-year basis.

The market capitalization of Bajaj Healthcare is ₹1,007 Crs, with a P/E ratio of 63.9 and a dividend yield of 0.50%.